Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Current surgical management of melanoma: A critical review of the best available evidence and practice guidelines in the United States Riker AI Skin Cancer Conference,association with the University of Queensland, Hamilton Island, Australia August, 2011
2. Current operative techniques for the management of melanoma and non-melanoma skin cancers Riker AI Skin Cancer Conference,association with the University of Queensland, Hamilton Island, Australia, August, 2011
3. A painful breast mass Riker AI LSUHSC, Department of Family Practice July, 2011
4. Combination immunotherapy for high-risk and advanced melanoma patients Riker AI American Society of Clinical Oncology (ASCO) June, 2011
5. Current Immunotherapy of Cancer Riker AI 4th Annual Perspectives in Oncology Meeting, New Orleans, Louisiana November, 2010
6. The Immunotherapy of Cancer Riker AI . Capital International Cancer Conference (CICC), Beijing Shijitan Hospital, Capital Medical University, China October, 2010
7. General surgery residency training and graduate medical education in the United States Riker AI Capital International Cancer Conference (CICC), Beijing Shijitan Hospital, Capital Medical University, China October, 2010
8. Surgical management of breast cancer Riker AI Capital International Cancer Conference (CICC), Beijing Shijitan Hospital, Capital Medical University, China October, 2010
9. Interaction of MCF-7 breast cancer cells with lymph node stromal cells enhances metastasis to lung and lymph nodes in NOD/SCID mice Lee CG, Lee Y, Sightler H, Riker AI, Choi YS Metastasis Research Society, Tumor Microenvironment Working Group, American Association of Cancer Research (AACR), Philadelphia, PA September, 2010
10. Surviving breast cancer Riker AI Cancer Support Group, Ochsner Cancer Institute August, 2010
11. Cancer Prevention: Focus on Skin Cancer and Melanoma Riker AI Shell Oil Corporate Employees July, 2010
12. Hello Health: Surviving Melanoma Riker AI WLAE News station, Cox Channel 14, Charter Channel 11 and Direct TV Channel 32 (60 minutes) July, 2010
13. Melanoma and Skin Cancer in the Aged Riker AI Golden Opportunities Event, Ochsner Medical Center, West bank, New Orleans Ladies Ballroom July, 2010
14. The Surgical Scientist Riker AI 4th Annual Research Day, Ochsner Medical Center, Department of Surgery June, 2010
15. A phase II clinical trial of a novel combinatorial anti-tumor immunotherapy for patients with high-risk, resected stage III and metastatic melanoma Riker AI American Society of Clinical Oncology (ASCO) June, 2010
16. Lessons Learned in Developing a Cancer Center and Research Program Riker AI Nevada Cancer Institute, Las Vegas, Nevada June, 2010
17. Breast Cancer in Older Women Riker AI Golden Opportunities Event, Ochsner Medical Center, West bank, Manhattan Health Club May, 2010
18. A phase II clinical trial of a novel combinatorial anti-tumor immunotherapy for patients with high-risk, resected stage III and metastatic melanoma Riker AI . Ochsner Cancer Institute, Research Night March, 2010
19. The Immunotherapy of Cancer Riker AI Basic Science in Clinical Medicine Series, Ochsner Cancer Institute January, 2010
20. Cancer, Am I at Risk Riker AI Laitrum Corporation, October, 2009
21. Cancer Prevention, Focus on Skin Cancer and Melanoma Riker AI (CME Event). Morgan City, Louisiana June, 2009
22. Genetic Predisposition to Breast Cancer and Surgical Treatment Options Riker AI Shell Oil Corporate Employees June, 2009
23. What Causes Cancer. Hello Health on TV,Health: Surviving Melanoma Riker AI Live television educational broadcasting. WLAE News station, Cox Channel 14, Charter Channel 11 and Direct TV Channel 32 (60 minutes) June, 2009
24. Ochsner-Baton Rouge, The Future of Comprehensive Cancer Care Riker AI Baton Rouge, Louisiana April, 2009
25. Skin Cancer Risk Riker AI Louisiana Electrolysis Association,Kenner, Louisiana April, 2009
26. Surviving Melanoma Riker AI Hello Health Lecture Series, Ochsner Cancer Institute, New Orleans, Louisiana March, 2009
27. Oncologic Immunotherapy Riker AI University of South Alabama, Department of Surgery, Grand Rounds, Mobile, Alabama February, 2009
28. Breast Cancer Awareness Month Riker AI How to Survive and Thrive after the Diagnosis of Breast Cancer October, 2008
29. Cutaneous Melanoma Riker AI The Epidemic Continues. Lunch and Learn Lecture Series, Children’s and Womens Hospital, Mobile, Alabama July, 2008
30. How to Survive Breast Cancer. Lunch and Learn Lecture Series Riker AI Children’s and Womens Hospital, Mobile, Alabama July, 2008
31. Identification of the WAP four-disulfide core domain 1 as a putative tumor suppressor gene in melanoma Liu S, Howell P, Ren S, Samant R, Riker AI Accepted for Poster Presentation to the American Association for Cancer Research (AACR), San Diego, California April, 2008
32. Identification of the putative oncogene, progesterone-associated endometrial protein (PAEP), in human melanoma Ren S, Liu S, Howell P, Samant R, Riker AI Annual Society of Surgical Oncology Meeting (SSO), Abstract Supp., February, Vol. 15(2), Chicago, Illinois March, 2008
33. Transcriptional Silencing of the Putative Oncogene, Testis-Specific Protein Y-linked, in Human Melanoma: Implications for Gene Demethylation Howell P, Liu S, Ren S, Samant R, Riker AI Annual Society of Surgical Oncology Meeting (SSO), Abstract Supp., February, Vol. 15(2), Chicago, Illinois March, 2008
34. Cancer Metastasis Riker AI, Cancer Metastasis University of South Alabama, Department of Surgery, Grand Rounds, Mobile, Alabama February, 2008
35. Differential proteomics of secreted proteins for melanoma biomarker discovery Rajesh M, Shevde LA, Samant RS, Riker AI, Pannell LK. Accepted for Poster Presentation, American Society of Mass Spectrometry, 56th Meeting January, 2008
36. How Cancer Develops and Spreads Riker AI University of South Alabama-Med School Café January, 2008
37. Surgical Oncology and the Mitchell Cancer Institute Riker AI Evergreen, Alabama November, 2007
38. The Mitchell Cancer Institute Riker AI Mobile Chapter of the Bar Association, Admiral Semmes Hotel October, 2007
39. Sentinel lymph node mapping in breast cancer, Science Café Riker AI Breast Cancer, USA chapter of Sigma Xi, University of South Alabama October, 2007
40. The Mitchell Cancer Institute: Focus on interdisciplinary cancer care Riker AI Dothan, Alabama, September, 2007
41. Advances in surgical oncology, Perspectives in Oncology Riker AI Mobile, Alabama August, 2007
42. Risky Rays: Reducing your skin cancer risk Riker AI Lunch and Learn Lecture Series, Infirmary West, Mobile, Alabama August, 2007
43. Gene expression profiling for breast cancer, Perspectives in Oncology Riker AI Plenary Speaker, Mobile, Alabama August, 2007
44. Genetic breast cancer, Perspectives in Oncology Riker AI Plenary Speaker, Mobile, Alabama August, 2007
45. Management of the axilla in cancer patients: The central role of sentinel lymph node mapping Riker AI , Jinan, China June, 2007
46. Breast Cancer Interdisciplinary approach to optimal patient management Riker AI Capital University, Beijing, China June, 2007
47. Residency education and training in the United States Riker AI Capital University, Beijing China June, 2007
48. Breast conservation therapy for patients with early stage breast cancer Riker AI Hangzhou, China June, 2007
49. Upregulation of Fanconi anemia DNA repair pathway in skin cancer Kao W, Riker AI, Enkemann S, Jove R, Buettner R, Sanchez N, Villa J, Sanchez J, Matta JL American Association for Cancer Research (AACR) April, 2007
50. The cyclin dependent kinase inhibitor roscovitine inhibits differentiation and invasion in a 3-dimensional skin reconstruction model of metastatic melanoma Mohapatra S, Coppola D, Riker AI, Pledger J American Association for Cancer Research (AACR), April, 2007
51. Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts Xi Y, Riker AI, Shevde L, Samant R, Gavin E, Fodstad O, Ju JJ American Association for Cancer Research (AACR) April, 2007
52. Cystatin M is a putative tumor suppressor gene in melanoma Briggs J, Maelandsmo G, Fodstad O, Riker AI American Association for Cancer Research (AACR) April, 2007
53. Current Management of Breast Cancer: From Surgery to Genetics of Breast Cancer Riker AI Bosom Buddies Breast Cancer Support Group,Thomas and Providence Hospital, Mobile, Alabama January, 2007
54. Upregulation of the Fanconi Anemia DNA repair pathway in metastatic melanoma Kao WH, Riker AI, Enkemann SA American Association for Cancer Research Annual Meeting January, 2007
55. Breast Cancer Update Riker AI University of South Alabama, Department of Internal Medicine, Grand Rounds (Part II), Mobile, Alabama December, 2006
56. Full thickness skin grafts procured from the sentinel lymph node basin: A comparison of methods Lewis JM, Riker AI, Puleo C, Reintgen D, Dessureault S, Cruse WC, Sondak VK 5th Biennial International Sentinel Node Society Meeting, Rome, Italy November, 2006
57. Current surgical management of breast cancer Riker AI Think Pink: Breast Cancer Awareness Month, Colonial Bel-Air Mall October, 2006
58. Technical Advances in Cancer Research Riker AI Lay Health Advisor Technology and Health Class. University of South Alabama (CME credit), October, 2006
59. Update on the surgical management of breast cancer Riker AI University of South Alabama, Children’s and Womens Hospital (CME credit) October, 2006
60. A gene specific model for tumor progression and metastatic potential correlates with melanoma tumor thickness Riker AI, Fodstad O, Ju J, Sondak VK, Messina J, Puleo C, Enkemann S, Daud A, Buettner R, Matta J Perspectives in Melanoma X, Society for Melanoma Research (combined meeting), Amsterdam, The Netherlands September, 2006
61. Comparative whole gene expression profiling yields a transition point for melanoma tumor progression Riker AI, Fodstad O, Ju J, Sondak VK, Messina J, Puleo C, Enkemann S, Daud A, Buettner R, Matta J Perspectives in Melanoma X, Society for Melanoma Research (combined meeting), Amsterdam, The Netherlands September, 2006
62. Surgical Oncology Riker AI University of South Alabama, Department of Surgery, Grand Rounds, Mobile, Alabama September, 2006
63. Multidisciplinary Cancer Care in the 21st Century: the Central Role of the Surgical Oncologist Riker AI University of South Alabama, Department of Internal Medicine, Grand Rounds, Mobile, Alabama September, 2006
64. Current Management of Melanoma. Lunch and Learn Lecture Series Riker AI Infirmary West Medical Center, Mobile, Alabama August, 2006
65. Early detection and prevention of breast cancer in underdeveloped countries: The importance of population-based screening programs Riker AI Hubei Province, Wuhan National Hospital, Wuhan, China July, 2006
66. Continuous Medical Education in the United States: Focus on International Collaborative Efforts Riker AI XuanWu Hospital, Capital University of Medical Sciences, Beijing, China July, 2006
67. Developing technologies in breast cancer management Riker AI 2nd Annual Breast Cancer Symposium, Hebei Province, Hebei Oriental Hospital, Shijiazhuang, China July, 2006
68. Advances in Breast Cancer Management Riker AI Lunch and Learn Lecture Series, Infirmary West Medical Center, Mobile, Alabama June, 2006
69. Comparative genetic interrogation of a primary melanoma and synchronous lymph node metastases from a single patient Riker AI, Jensen EH, Lewis JM, Alvarado M, Puleo CA, Messina J, Sondak VK, Daud A, Enkemann S, Yeatman TJ Poster presentation, Society of Surgical Oncology (SSO) Annual Meeting March, 2006
70. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma Jensen EH, Lewis JM, Alvarado M, Puleo CA, Messina J, Sondak VK, Daud A, Enkemann S, Yeatman TJ, Riker AI Oral presentation, Society of Surgical Oncology (SSO) Annual Meeting March, 2006
71. Comparison of full and partial thickness skin grafts utilized for closure of soft tissue defects in cutaneous malignancy Lewis JM, Puleo C, Riker AI, Reintgen D, Dessureault S, Cruse WC, Sondak VK Joint Cancer Conference of the Florida Universities, Palm Beach, Florida January, 2006
72. IFGBP-3 expression is associated with tumor progression in melanoma Xi Y, Nakajima G, Hamil T, Fodstad O, Riker AI, Ju J Keystone Melanoma Conference, 206, 102 January, 2006
73. The farnesyl transferase (FTase) inhibitor (FTI) tipifarnib inhibits FTase in vivo and enhances the efficacy of neoadjuvant dose-dense doxorubicin-cyclophosphamide (AC) in patients with locally advanced breast cancer Moulder SL, Sparano JA, Kazi A, Wright J, Munster P, Vahdat L, Minton S, Hershman D, Diaz N, Malafa M, Riker AI, Lee D, Pellegrino C, Li T, Negassa A, Sebti S San Antonio Breast Cancer Symposium (SABCS) December, 2005
74. General surgery residency training and graduate medical education Riker AI United States, Xuan Wu Hospital, Capital University of Medical Sciences, Beijing, China December, 2005
75. importance of breast cancer screening in underdeveloped countries Riker AI North China Coal Hospital and Medical College, Tangshan, Hebei Province, China, December, 2005
76. International issues related to breast cancer care Riker AI Beijing WuZhou Female Hospital, Beijing, China December, 2005
77. Significance of sentinel lymph node micrometastasis on survival for patients with invasive breast cance Cox C, Vrcel V, Riker AI, White L, Allred N, Ramos D, Myers M, Dupont E, King J, Cantor A, Diaz N Oral presentation at the San Antonio Breast Cancer Symposium (SABCS), December, 2005
78. Melanoma in Florida: The Current State of Affairs Riker AI Brighthouse Networks Bay Today, Channel 47, Tampa, Florida November, 2005
79. Comparisons of methodology for the selective depletion of murine CD4+CD25+ T-cells Matsushita N, Riker AI, Kuhn L, Mule’ JJ, Pilon-Thomas P 20th Annual Meeting of the International Society of Biological Therapy for Cancer, Alexandria, Virginia, November, 2005
80. Featured speaker on the surgical management of breast cancer Riker AI 8th Annual Sarasota/Manatee/Moffitt Women’s Cancer Awareness Luncheon, Sarasota, Florida October, 2005
81. Surgical staging and mapping for melanoma Riker AI Sentinel Lymph Node Mapping Course, Tampa, Florida October, 2005
82. The genetic progression of melanoma Riker AI Savannah/Candler Cancer Center, Savannah, Georgia September, 2005
83. Surgical procurement of melanoma: Implications for the genetic behavior of melanoma Riker AI NIA/NIH, Baltimore, Maryland September, 2005
84. The use of DNA microarray to determine potential pathways of tumor metastasis Moulder SL, Escherich S, Dupont E, Riker AI, Cox CE, Furman B, Carter B, Enkemann SA, Yeatman T, Diaz N Era of Hope, Department of Defense Breast Cancer Research Program, Philadelphia, Pennsylvania June, 2005
85. Surgical staging and mapping for melanoma Riker AI Sentinel Lymph Node Mapping Course, Tampa, Florida May, 2005
86. The genetic progression of melanoma Riker AI Mobile, Alabama April, 2005
87. Treatment with TNF-I matured DC exacerbates disease progression in a murine lung metastasis model Pilon-Thomas S, Verhaegen M, Riker AI, Mulé JJ American Association of Immunologists (AAI) Annual Meeting, in conjunction with Experimental Biology, San Diego California April, 2005
88. First in human Phase I trial of plasmid IL-12 electro-gene-therapy in patients with malignant melanoma Daud A, DeConti R, Messina JL, Andrews S, Urbas P, Ugen K, Puleo CA, Sondak VK, Riker AI, Heller R Poster presentation, American Association for Cancer Research (AACR) Annual Meeting April, 2005
89. Plastic and reconstructive options for patients with breast cancer. Current issues in breast conservation therapy for patients with early stage breast cancer Riker AI Sun-Yat-Sen University and Memorial Hospital, Guangzhou, China March, 2005
90. Treatment of DCIS in a patient previously treated with mantle radiation for non-Hodgkins lymphoma: Novel adjuvant treatment options Riker AI, Dupont EL, Wilke K, Cox CE American Society of Breast Surgeons 6th Annual Meeting, Oral presentation at the “Community Tumor Board”, Los Angeles, California March, 2005
91. Melanoma patients with positive sentinel nodes who do not undergo completion lymphadenectomy: A multi-institutional study Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SPL, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, and Coit DG Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, Georgia March, 2005
92. Comparative gene expression profiling of a melanoma arising from an atypical nevus: A novel approach to the interrogation of tumor genetics Jensen E, Alvarado M, Lee A, Puleo CA, Sondak V, Yeatman TJ, Riker AI Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, Georgia, March, 2005
93. Regional lymph node micrometastases: A prognostic indicator independent of breast carcinoma size Cox C, Vrcel V, Riker AI, White L, Allred N, Ramos D, Myers M, Dupont E, King J, Cantor A, Diaz N United States and Canadian Academy of Pathology Annual Meeting January, 2005
94. Current issues in breast conservation therapy for patients with early stage breast cancer Riker AI Sun-Yat-Sen University and Memorial Hospital, Guangzhou, China January, 2005
95. Clark’s level should not be considered alone as a criteria for sentinel node biopsy in thin melanoma Puleo C, Messina J, Cruse CW, Riker AI, Reintgen D, Sondak V 4nd International Sentinel Node Congress, Santa Monica California December, 2004
96. Pilon-Thomas S, Kuhn L, Koike N, Li WB, Mulé JJ: Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine model Pilon-Thomas S, Kuhn L, Koike N, Li WB, Riker AI, Mulé JJ 19th Annual Meeting of the International Society of Biological Therapy for Cancer, San Francisco, California November, 2004
97. Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with IgG opsonized tumor cells Riker AI 19th Annual Meeting of the International Society of Biological Therapy for Cancer, San Francisco, California, November, 2004
98. Cancer Update 2004: Melanoma Detection and Prevention Riker AI Home Shopping Network Corporation, St. Petersburg, Florida August, 2004
99. Cancer Update 2004: Plenary Lecture, Immunotherapy of Breast Cancer Riker AI University of Michigan Comprehensive Cancer Center, Bay Harbor, Michigan July, 2004
100. Skin Cancer Prevention Riker AI TECO Corporation, Tampa, Florida July, 2004
101. Current Surgical Therapy for Breast Cancer Riker AI North Broward County Medical Center, Fort Lauderdale, Florida July, 2004
102. Current Surgical Therapy for Breast Cancer, Riker AI Parrish Medical Center, Doctors’ Goodwill Foundation Expo 2004, Titusville, Florida May, 2004
103. Current Therapy for Melanoma Patients Riker AI Corporate Partners Steering Committee of Tampa Bay, Tampa, Florida April, 2004
104. Breast Cancer Update Riker AI Tallahassee Memorial Cancer Center in collaboration with the Syncure Foundation April, 2004
105. The Role of PET Scanning in the Diagnosis, Staging and Follow-up of Melanoma Patients Riker AI The 1st International Symposium on Melanoma and other Cutaneous Malignancies, New York City, April, 2004
106. The Current Role of Breast Conservation Therapy for Early Stage Breast Cancer Riker AI Cancer Institute, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China February, 2004
107. Metastatic Melanoma: Recent Surgical Advances Riker AI Joint Cancer Conference of the Florida Universities. Orlando, Florida February, 2004
108. The Role of Sentinel Lymph Node Biopsy in Breast Cancer Riker AI The First Affiliated Hospital of Nanhua University, Hunan, China February, 2004
109. The Immunotherapy of Breast Cancer Riker AI Sun-Yat-Sen University and Memorial Hospital , Guangzhou, China February, 2004
110. Current Surgical Concepts for Breast Cancer Riker AI Tong Ji Hospital and Medical College, Huazhong University of Science and Technology, Wuhan, China February, 2004
111. Melanoma on the rise. Tampa’s Education Channel and Moffitt Cancer Center for Taking Control of Cancer, a 12-part series focusing on the latest advances in cancer research, treatment, screening and prevention Riker AI, Pilon-Thomas S, Kuhn L, Koike N, Li WB, Mulé JJ The Education Channel, Tampa, Florida January, 2004
112. The Big Picture-From Surgery to Survivorship Riker AI Sixteen Annual Breast Cancer Education Fall Conference, FACTors (Fighting Against Cancer Together) Breast Cancer Patient Support Program, H. Lee Moffitt Cancer Center and Research Institute October, 2003
113. Learning About Cancer, I Can Cope, An Educational Series Designed for Cancer Patients Riker AI Psychosocial and Palliative Care Program, H. Lee Moffitt Cancer Center and Research Institute October, 2003
114. Advances in the Surgical Treatment of Melanoma Riker AI Melanoma Regional Symposium, Vincent A. Stabile Research Center, H. Lee Moffitt Cancer Center and Research Institute October, 2003
115. Current Concepts in Breast Cancer Riker AI FACTors (Fighting Against Cancer Together) Breast Cancer Patient Support Program, H. Lee Moffitt Cancer Center and Research Institute June, 2003
116. Saving your skin: An Update on Melanoma Detection and Prevention Riker AI Speaking of Women’s Health Conference, presented by WEDU, Sarasota, Florida May, 2003
117. The Surgical Management of Breast Cancer Riker AI Department of Anesthesia, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois March, 2003
118. Recent Developments in Melanoma Treatment Riker AI Department of Plastic Surgery, Grand Rounds, Loyola University Medical Center, Maywood, Illinois, January, 2003
119. The Surgical Abdomen Riker AI Mechanisms of Human Disease, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois January, 2003
120. Dendritic Cell-Based Immunotherapy for Advanced Malignancies Riker AI Clinical and Translational Seminar Series, Cardinal Bernardin Cancer Center, September, 2002
121. Melanoma in the New Millennium Riker AI Operating Room Staff Grand Rounds, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois September, 2002
122. Tumor Escape Mechanisms within the Host/tumor Microenvironment Riker AI University of Zurich, Department of Dermatology and Experimental Immunotherapy, Zurich, Switzerland, April April, 2002
123. Molecular Basis of Melanoma Riker AI Overcoming the dogma of the last 100 years. The Curie Institute, Paris, France April, 2002
124. Cytoreductive Surgery as a Form of Adjuvant Immunotherapy for Patients with stage IV Melanoma Riker AI National Cancer Institute, Department of Tumor Immunobiology and Immunotherapy, Milan, Italy, April April, 2002
125. Open Roux-en-Y gastric bypass for the morbidly obese Reddy RA, Riker AI, Brems JJ Still the gold standard for bariatric surgery, Southwestern Surgical Association December, 2001
126. Molecular Analysis, Immunosurveillance and Immune Escape Mechanisms in Patients with Stage IV Melanoma Riker AI State of the Art in the New Millenium. Upstate Medical Center, Syracuse University, Syracuse, New York December, 2001
127. Immunological Monitoring of Vaccine Trials Riker AI Symposium on the innovations in treatment and immunological monitoring of advanced melanoma, Cardinal Bernardin Cancer Center, Maywood, Illinois November, 2001
128. Experimental treatment options for patients with metastatic melanoma Riker AI H.Lee Moffitt Cancer Center & Research Institute, Grand Rounds, Tampa, Florida November November, 2001
129. Treatment of metastatic melanoma in the new millenium. Taussig Cancer Center Riker AI Cleveland Clinic Foundation, Cleveland, Ohio November, 2001
130. Dendritic cell -based immunotherapy of metastatic melanoma Riker AI Department of General Surgery, Grand Rounds, Loyola University Medical Center, Maywood, Illinois September, 2001
131. Experimental treatment options for patients with metastatic melanoma Riker AI Department of Plastic Surgery, Grand Rounds, Loyola University Medical Center, Maywood, Illinois, June, 2001
132. Promotor activity relevant for expression of gp100 by melanocytic cells LePoole IC, Riker AI, Stennett, LS, Miki, T Society for Pigment Cell Research January, 2001
133. Melanoma 2000: A new era of treatment based on the genes that encode cancer Riker AI Grand Rounds, Loyola University Medical Center, Maywood, Illinois December, 2000
134. Melanoma antigen expression in serial fine needle aspiration samples in patients with metastatic melanoma participating in immunotherapy clinical trials Fetsch PA, Riker AI, Steinberg, SM, Marincola FM, Abati A United States and Canadian Academy of Pathology September, 2000
135. Antigen loss variants in melanoma LePoole IC, Nickoloff BJ, Riker AI, Dee L, Stennett LS, Swan J, Robinson JK Potential induction by interferon-gamma. IX Annual Meeting of the Pan-American Society for Pigment Cell Research June, 2000
136. The utility of sentinel lymph node biopsy in patients with melanoma Riker AI The Burn and Shock Trauma Institute Seminar Series, Loyola University Medical Center, Maywood, Illinois May, 2000
137. Detection of circulating melanoma cells utilizing HMB-45 and MART-1, via a combination of membrane permeabilization and immunomagnetic beads Fetsch PA, Riker AI, Ohnmacht, G., Marincola FM, Sorbara, L., Abati A United States and Canadian Academy of Pathology March, 2000
138. Tyrosinase Immunoreactivity in fine needle aspiration samples of metastatic malignant melanoma: Fixation methods yield variable results Fetsch PA, Riker AI, Marincola FM, Abati A United States and Canadian Academy of Pathology March, 2000
139. Peptide-based immunotherapy of patients with metastatic melanoma Riker AI The Burn and Shock Trauma Institute Seminar Series. Loyola University Medical Center, Maywood, Illinois February, 2000
140. Threshold levels of gene expression of the melanoma antigen, gp100, determine tumor cell recognition by cytotoxic T-lymphocytes Riker AI, Panelli MC, Kammula U, Wang E. Lee KH, Steinberg SM, Rosenberg SA and Marincola FM 85th Clinical Congress of the American College of Surgeons, Surgical Forum, San Francisco, California, October, 1999
141. The utility of fine needle aspiration biopsy in the prospective analysis of patients with metastatic melanoma Riker AI Tumor Board, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, Illinois August, 1999
142. Expansion of tumor infiltrating lymphocytes /Tumor pairs from fine needle aspirates of melanoma metastases Panelli MC, Riker AI, Kammula US, Wang E, Lee KH, Rosenberg SA, Marincola FM American Association of Immunologists annual meeting, Washington, D.C April, 1999
143. Immune selection following antigen specific immunotherapy of melanoma Riker AI, Panelli MC, Kammula U, Wang E. LeeK-H, Steinberg SM, Rosenberg SA and Marincola FM Accepted for oral presentation at 60th Annual Meeting of the Society of University Surgeons, New Orleans February, 1999
144. Immune selection in response to peptide based immunotherapy Riker AI, Panelli MC, Wang E., Steinberg SM, Rosenberg SA and Marincola FM Society of University Surgeons, New Orleans, Louisiana February, 1999
145. The multiple ways to tumor tolerance Marincola FM, Riker AI, Panelli MC, Wang E, and K-H Lee NCI combined intramural principal investigator retreat: January 7-8, 1999: Abstract book: 118 January, 1999
146. Tumor Selection in Response to peptide based immunotherapy Riker AI National Institutes of Health, National Cancer Institute November, 1998
147. New advances in the evaluation of the immunobiology of melanoma. Cancer Det. Prev Riker AI and Marincola FM International Society for Preventive Oncology 4th International Symposium on the Impact of Cancer Biotechnology on Predictive Oncology and Therapy, Nice, France October, 1998
148. Evaluation of response to vaccination trials: advances, pitfalls and paradoxes Riker AI and Marincola FM 1st International Symposium on Melanoma June, 1998
149. Dissociation between local and systemic T cell response following melanoma antigen (MA) specific vaccination Panelli MC, Lee K-H., Kim CJ, Riker AI, Wunderlich J, Rosenberg SA and Marincola FM American Association of Cancer Research annual meeting, New Orleans, LA 1998. Proceedings 39: 357 January, 1998
150. Oligoclonal expansion and localization of CTL with low epitope avidity after MAA peptide based vaccination Lee K-H, Panelli MC, Kim JC, Riker AI and Marincola FM Oral presentation: ASHI, 1998. Human Immunol, 59 (supp 1): 4 January, 1998
151. Dissociation between local and systemic T cell response following melanoma antigen (MA) specific vaccination Marincola FM, Panelli MC, Kim JC, Riker AI, Wunderlich J., Rosenberg SA and K-H Lee . NCI combined intramural principal investigator retreat: December 4-5, 1997: Abstract book: 126 December, 1997



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Surgical management of melanoma: what is the evidence and what is best practice? Skin Cancer Conference August, 2011

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.